Recurrent Pericarditis

Pericarditis recurrence in lupus is more likely — and has a dose-dependent relationship — with oral prednisone treatment, though overall it is lower than in the general population, according to data published in JAMA Network Open.

Healio | Cardiology Today has compiled a list of the topic headlines of August 2023 in cardiology.

Acute and recurrent pericarditis are the most common pericardial syndromes and represent an etiology of chest pain that is associated with substantial morbidity, decreased quality of life and, rarely, mortality.

Advances in imaging techniques and new treatments are changing the management of recurrent pericarditis, improving outcomes for patients with formerly treatment-resistant disease, researchers reported.

The FDA announced it approved rilonacept injection to treat and reduce risk for recurrent pericarditis in adults and children 12 years and older.

Rilonacept (Kiniksa Pharmaceuticals) as treatment for patients with recurrent pericarditis.

In patients with recurrent pericarditis, compared with placebo, rilonacept better resolved recurrent episodes and lowered risk for future episodes, according to data presented at the virtual American Heart Association Scientific Sessions.